| 26/765 |
Complaints & Clinical Negligence Claims Regarding Use of AI |
| 26/764 |
Early Non-Small Cell Lung Cancer Treatments |
| 26/755 |
Violence and Aggression |
| 26/741 |
Treatment of Cancers |
| 26/731 |
Treatment with Immunology Medicines - Gastroenterology & Rheumatology |
| 26/723 |
Patient-Safety Incidents |
| 26/719 |
Unpaid Debts of 2 Months |
| 26/718 |
Guidelines on the Treatment of Interstitial Lung Diseases (ILD) |
| 26/709 |
Vascular Access Services |
| 26/707 |
Migraine |
| 26/703 |
Bullying and Harassment Policy |
| 26/699 |
Lung Cancer |
| 26/698 |
Child Sexual Exploitation |
| 26/697 |
Clinical Negligence Liabilities |
| 26/695 |
FOI System/Process |
| 26/692 |
Usage of High-cost Drugs in Ophthalmology |
| 26/687 |
IT Spend FY 2025/26 |
| 26/686 |
Bed Bug Infestations or Incidents |
| 26/683 |
Biologics Medicines in Gastroenterology |
| 26/682 |
Oncology Diagnosis & Treatment |
